Alert detail

LCD L38051: MolDX: Pigmented Lesion Assay — Palmetto GBA

Policy ID: LCD-L38051Specialty: DermatologyAdded: 9/12/2026Effective: June 20, 2024lcd
Low

What changed

Palmetto GBA finalizes coverage rules for melanoma molecular assay.

Who’s affected: Dermatology billing teams · Effective: June 20, 2024

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 7 billing codes.

The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.